Patient P-01852

Synthetic patientNBL-101 · Day 114 · 65–74 · F · baseline S02Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Improving

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S02

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Nutritional resilience+7
Treatment adherence+6
Inflammatory activity-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

13.9/100

worsening · +10.9 vs previous 14 d

Toxicity

Blood

14.8/100

worsening · +1.0 vs previous 14 d

Sleep quality

Wearable

19.3/100

worsening · -8.7 vs previous 14 d

Energy level

Daily log

6.6/10

worsening · -0.4 vs previous 14 d

Stress level

Daily log

3.4/10

worsening · +0.4 vs previous 14 d

Steps

Wearable

10,947

worsening · -528 vs previous 14 d

Adherence

Companion

98.2 %

stable · +0.3 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading drifting · 94 from the failing basin, 9 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3

Main detractors to watch

FUT2 non-secretor
hidden · steering -10.6
Histamine load
perturbation · steering -6.3
Poor-sleep week
perturbation · steering -3
Low-HRV stretch
perturbation · steering -2.7
Histamine load
detractor · GI +3.5 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Histamine load
+3.5detractor · 95%
Insoluble fibre
-1.5no signal · 51%
Simple carbohydrates
+0.9no signal · 25%
Dietary fat load
+0.6no signal · 15%
Alcohol
+0.5no signal · 16%
Spicy / capsaicin
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓40
- DNAFUT2 non-secretor lowers mucosal fucosylation
- WearableSleep 5.0 h, below personal baseline
Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

FUT2 rs601338 AA (non-secretor)
Reduced mucosal fucosylation
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.4 · butyrate capacity 61/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 41 ms
Sleep: 6.0 h
Steps: 10,042
Resting HR: 70 bpm

Daily log: GI score 14, nutritional resilience 74, adherence 98.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	44%	S05	AD-05	no change	90
P-01804	29%	S19	AD-05	improved	61
P-01541	24%	S09	AD-05	no change	43
P-01495	45%	S07	BR-03	improved	85
P-01329	43%	S08	BR-03	improved	79
P-01677	41%	S05	BR-03	no change	86
P-01654	47%	S08	CR-01	improved	85
P-01430	25%	S05	CR-01	improved	54
P-01479	38%	S15	DT-01	improved	84
P-01855	36%	S04	DT-01	improved	73
P-01724	29%	S10	DT-01	improved	63
P-01767	29%	S14	DT-01	no change	63